Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

A model for medication safety event detection.

Snyder RA, Fields W.

Int J Qual Health Care. 2010 Jun;22(3):179-86. doi: 10.1093/intqhc/mzq014. Epub 2010 Mar 27.

2.

Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.

Takata GS, Mason W, Taketomo C, Logsdon T, Sharek PJ.

Pediatrics. 2008 Apr;121(4):e927-35. doi: 10.1542/peds.2007-1779.

PMID:
18381521
3.

Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment.

Ferranti J, Horvath MM, Cozart H, Whitehurst J, Eckstrand J.

Pediatrics. 2008 May;121(5):e1201-7. doi: 10.1542/peds.2007-2609.

PMID:
18450863
4.

Detecting medication errors in the New Zealand pharmacovigilance database: a retrospective analysis.

Kunac DL, Tatley MV.

Drug Saf. 2011 Jan 1;34(1):59-71. doi: 10.2165/11539290-000000000-00000.

PMID:
21142271
5.

Identifying drug safety issues: from research to practice.

Gandhi TK, Seger DL, Bates DW.

Int J Qual Health Care. 2000 Feb;12(1):69-76. Review.

PMID:
10733086
6.

Preventable and non-preventable adverse drug events in hospitalized patients: a prospective chart review in the Netherlands.

Dequito AB, Mol PG, van Doormaal JE, Zaal RJ, van den Bemt PM, Haaijer-Ruskamp FM, Kosterink JG.

Drug Saf. 2011 Nov 1;34(11):1089-100. doi: 10.2165/11592030-000000000-00000.

PMID:
21981436
7.

Characterising the complexity of medication safety using a human factors approach: an observational study in two intensive care units.

Carayon P, Wetterneck TB, Cartmill R, Blosky MA, Brown R, Kim R, Kukreja S, Johnson M, Paris B, Wood KE, Walker J.

BMJ Qual Saf. 2014 Jan;23(1):56-65. doi: 10.1136/bmjqs-2013-001828. Epub 2013 Sep 19.

8.

Medication safety program reduces adverse drug events in a community hospital.

Cohen MM, Kimmel NL, Benage MK, Cox MJ, Sanders N, Spence D, Chen J.

Qual Saf Health Care. 2005 Jun;14(3):169-74.

9.

Adverse drug events in older hospitalized patients: results and reliability of a comprehensive and structured identification strategy.

Klopotowska JE, Wierenga PC, Stuijt CC, Arisz L, Dijkgraaf MG, Kuks PF, Asscheman H, de Rooij SE, Lie-A-Huen L, Smorenburg SM; WINGS Study Group.

PLoS One. 2013 Aug 5;8(8):e71045. doi: 10.1371/journal.pone.0071045. Print 2013.

10.

Adverse drug event detection in pediatric oncology and hematology patients: using medication triggers to identify patient harm in a specialized pediatric patient population.

Call RJ, Burlison JD, Robertson JJ, Scott JR, Baker DK, Rossi MG, Howard SC, Hoffman JM.

J Pediatr. 2014 Sep;165(3):447-52.e4. doi: 10.1016/j.jpeds.2014.03.033. Epub 2014 Apr 25.

11.

Incidence, preventability, and impact of Adverse Drug Events (ADEs) and potential ADEs in hospitalized children in New Zealand: a prospective observational cohort study.

Kunac DL, Kennedy J, Austin N, Reith D.

Paediatr Drugs. 2009;11(2):153-60. doi: 10.2165/00148581-200911020-00005.

PMID:
19301935
12.

Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.

Carnevali L, Krug B, Amant F, Van Pee D, Gérard V, de Béthune X, Spinewine A.

Ann Pharmacother. 2013 Nov;47(11):1414-9. doi: 10.1177/1060028013500939.

PMID:
24285758
13.

Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.

Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, Laffel G, Sweitzer BJ, Shea BF, Hallisey R, et al.

JAMA. 1995 Jul 5;274(1):29-34.

PMID:
7791255
14.
15.

Strategies for detecting adverse drug events among older persons in the ambulatory setting.

Field TS, Gurwitz JH, Harrold LR, Rothschild JM, Debellis K, Seger AC, Fish LS, Garber L, Kelleher M, Bates DW.

J Am Med Inform Assoc. 2004 Nov-Dec;11(6):492-8. Epub 2004 Aug 6.

16.

Preventable adverse drug events and their causes and contributing factors: the analysis of register data.

Jylhä V, Saranto K, Bates DW.

Int J Qual Health Care. 2011 Apr;23(2):187-97. doi: 10.1093/intqhc/mzq085. Epub 2011 Jan 17.

PMID:
21242162
17.

Automated surveillance for adverse drug events at a community hospital and an academic medical center.

Kilbridge PM, Campbell UC, Cozart HB, Mojarrad MG.

J Am Med Inform Assoc. 2006 Jul-Aug;13(4):372-7. Epub 2006 Apr 18.

18.

Electronic medication reconciliation and medication errors.

Hron JD, Manzi S, Dionne R, Chiang VW, Brostoff M, Altavilla SA, Patterson AL, Harper MB.

Int J Qual Health Care. 2015 Aug;27(4):314-9. doi: 10.1093/intqhc/mzv046. Epub 2015 Jun 29.

PMID:
26130746
19.

Identifying Medication-Related Adverse Drug Events in Nursing Facilities in East Texas.

Tenhunen ML, Smithers B, Tucker B.

Consult Pharm. 2016;31(8):436-9. doi: 10.4140/TCP.n.2016.436.

PMID:
27535078
20.

Adverse drug events and medication errors: detection and classification methods.

Morimoto T, Gandhi TK, Seger AC, Hsieh TC, Bates DW.

Qual Saf Health Care. 2004 Aug;13(4):306-14.

Supplemental Content

Support Center